Our Network US Food and Drug Administration accepts for review AstraZeneca’s Supplemental Biologics License Application for self-administration of FluMist Quadrivalent Tags: #Research #Vaccines #AstraZeneca #Regulation Potential to be the first and only self-administered flu vaccine.
